nocodazole has been researched along with lactacystin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aksenov, ND; Kislyakova, TV; Malashicheva, AB; Osipov, KA; Pospelov, VA | 1 |
Kisliakova, TV; Malashicheva, AB; Pospelov, VA; Savatier, P | 1 |
Harashima, H; Kogure, K; Moriguchi, R; Nakamura, T; Shastri, N | 1 |
3 other study(ies) available for nocodazole and lactacystin
Article | Year |
---|---|
F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
Topics: Acetylcysteine; Animals; Apoptosis; Carcinoma, Embryonal; CDC2-CDC28 Kinases; Cell Cycle; Cyclin B; Cyclin B1; Cyclin D1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; DNA Damage; G1 Phase; Gamma Rays; Mice; Multienzyme Complexes; Nocodazole; Promoter Regions, Genetic; Proteasome Endopeptidase Complex; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; S Phase; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2000 |
[Embryonal stem cells do not undergo cell cycle arrest upon exposure to damaging factors].
Topics: Acetylcysteine; Animals; Aspartic Acid; Cell Cycle; Cell Line; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Doxorubicin; Embryo, Mammalian; Mice; Nocodazole; Phosphonoacetic Acid; Stem Cells; Tumor Cells, Cultured | 2002 |
Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes.
Topics: Acetylcysteine; Amiloride; Animals; Antigen Presentation; Bone Marrow Cells; Cell Line, Tumor; Cells, Cultured; Dendritic Cells; Flow Cytometry; Histocompatibility Antigens Class I; Intracellular Space; Liposomes; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Neoplasms, Experimental; Nocodazole; Oligopeptides; Tumor Burden | 2008 |